Basit öğe kaydını göster

Reawakening of Human Fetal Hemoglobin and an Epigenetic Path to the Clinic for Sickle Cell Disease and Beta-Thalassemia: Identification of an Orally-Available, Potent, and Selective Euchromatic Histone Lysine Methyltransferase 1 and 2 ( EHMT1/2) Inhibitor

dc.contributor.authorChan-Penebre, Elayne
dc.contributor.authorGibaja, Veronica
dc.contributor.authorCampbell, John
dc.contributor.authorOlu, Ogunbodede
dc.contributor.authorAdmirand, Elizabeth
dc.contributor.authorBrach, Dorothy
dc.contributor.authorTang, Cuyue
dc.contributor.authorRaimondi, Alejandra
dc.contributor.authorHood, Tami
dc.contributor.authorCocozaki, Alexis
dc.contributor.authorKARAMAN, Şule
dc.contributor.authorStickland, Kimberly
dc.contributor.authorPlescia, Christopher
dc.contributor.authorMunchhof, Michael
dc.contributor.authorArmstrong, Kelli
dc.contributor.authorRiera, Thomas
dc.contributor.authorOrkin, Stuart
dc.contributor.authorBoriack-Sjodin, Ann
dc.contributor.authorJanzen, William
dc.contributor.authorBlakemore, Stephen
dc.contributor.authorRibich, Scott A.
dc.contributor.authorChesworth, Richard
dc.contributor.authorSmith, Jesse J.
dc.contributor.authorDuncan, Kenneth W.
dc.date.accessioned2022-02-18T09:51:57Z
dc.date.available2022-02-18T09:51:57Z
dc.identifier.citationChan-Penebre E., Gibaja V., Campbell J., Olu O., Admirand E., Brach D., Tang C., Raimondi A., Hood T., Cocozaki A., et al., "Reawakening of Human Fetal Hemoglobin and an Epigenetic Path to the Clinic for Sickle Cell Disease and Beta-Thalassemia: Identification of an Orally-Available, Potent, and Selective Euchromatic Histone Lysine Methyltransferase 1 and 2 ( EHMT1/2) Inhibitor", 59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130
dc.identifier.othervv_1032021
dc.identifier.otherav_65ffd444-4658-4a12-8054-60b3ffa627cc
dc.identifier.urihttp://hdl.handle.net/20.500.12627/178126
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectHematology
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.titleReawakening of Human Fetal Hemoglobin and an Epigenetic Path to the Clinic for Sickle Cell Disease and Beta-Thalassemia: Identification of an Orally-Available, Potent, and Selective Euchromatic Histone Lysine Methyltransferase 1 and 2 ( EHMT1/2) Inhibitor
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume130
dc.contributor.firstauthorID3385803


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster